ChIRP(Chromatin Isolation by RNA Purification)是一項研究RNA與DNA及蛋白質之間相互作用的技術。根據研究對象不同,ChIRP技術可分別結合高通量測序(ChIRP-Seq)和質譜技術(ChIRP-MS),研究與目標RNA互作的基因和蛋白質。 (本試劑盒僅供科研用途)
實驗原理:
ChIRP方法通過設計生物素標記RNA互補探針,并使其與鏈霉親和素結合,這樣,在探針與目標RNA特異性結合的同時,捕獲RNA結合調控的DNA染色體片段與參與轉錄調控的RNA結合蛋白質(RBPs)。
DNA染色體片段經過文庫構建與高通量測序,在基因組水平上獲得轉錄調控RNA(增強子RNA, eRNA)調控的下游靶基因,結合qPCR可以研究結合調控強度; RNA結合蛋白經過酶消化與高效液相-質譜分析,可以鑒定參與轉錄調控的蛋白質,結合Western Blot可以進一步研究結合作用強度。
產品優勢:
1. 伯信獨立研發,具有自主知識產權。
2. 特異性和靈敏度高,穩定性好。
3. 檢測方法領先,結果準確、重復性好。
4. 快速檢測,操作簡單,安全便捷。
技術路線:

結果實例:
詳見產品說明書:Bes5104-2 ChIRP-Protein
詳見產品說明書:Bes5104-3 ChIRP-DNA、Protein
注:Bes5104-3 ChIRP-DNA&Protein (同時拉RNA結合DNA和蛋白)的用戶可根據實驗目的自行參考說明書Bes5104-1 ChIRP-DNA(只研究RNA結合DNA) 或Bes5104-2 ChIRP-Protein (只研究RNA結合蛋白)進行實驗操作。
文章案例
【2025年】
Periodicals:Signal Transduction and Targeted Therapy
IF:40.800
Periodicals:Cancer Communications (London, England)
IF:24.900
Periodicals:Nature Communications
IF:15.700
Article:o8G-modified circKIAA1797 promotes lung cancer development by inhibiting cuproptosis.
Periodicals:Journal of Experimental & Clinincal Cancer Research: CR
IF:11.400
Periodicals:Journal for Immunotherapy of Cancer
IF:10.600
【2024年】
Article: Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.
Periodicals:Military Medical Research
IF:16.700
Periodicals:Advanced Science
IF:14.300
Periodicals:Advanced Science
IF:14.300
Article: LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B.
Periodicals:Journal of experimental & clinical cancer research
IF:11.400
Article:Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma.
Periodicals:Journal of experimental & clinical cancer research
IF:11.400
Periodicals:Cell death & Disease
IF:8.100
Periodicals:BMC Medicine
IF:7.000
Periodicals:Cellular and Molecular Life Sciences
IF:6.200
Periodicals:Cell cycle (Georgetown, Tex.)
IF:3.400
【2023年】
Periodicals:Molecular Cancer
IF:37.2999
Periodicals:International Journal of Biological Sciences
IF:9.200
Periodicals:International Journal of Molecular Sciences
IF:5.600
Periodicals:Cancer Cell International
IF:5.800
【2022年】
Periodicals:Biomarker Research
IF:11.100
Periodicals:Cell Death and Disease
IF:9.000
Periodicals:Cellular and molecular life sciences
IF:6.200
Periodicals:Molecular Medicine
IF:5.700
【2021年】
Periodicals:Clinical and Translational Medicine
IF:10.600
Article:Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
Periodicals:Frontiers in Oncology
IF:6.244
【2020年】
Article:Long Noncoding RNA MRPL23-AS1 Promotes Adenoid Cystic Carcinoma Lung Metastasis
Periodicals:Cancer Research
IF:11.200
Article:Super-Enhancer LncRNA LINC00162 Promotes Progression of Bladder Cancer
Periodicals:iScience
IF:4.447
【2019年】
Periodicals:Advanced Science
IF:17.521
【2017年】
Periodicals:Journal of Cellular and Molecular Medicine
IF:4.302



